Mineralocorticoid receptor antagonist therapy safely controls blood pressure and potassium levels before adrenalectomy ...

Deciphering how the GR forms oligomers—through the binding of several subunits—opens a crucial avenue for developing more ...

Over the past two decades there have been tremendous advancements in the understanding of both the prevalence and the ...

Mineralocorticoid receptor antagonists (MRAs) reduced the risk of cardiovascular death or heart failure (HF) hospitalization in patients with HF and reduced ejection fraction (HFrEF) and also in those ...

Drugs to treat inflammatory and autoimmune diseases - such as asthma, psoriasis, rheumatoid arthritis or Chrousos syndrome - ...

A team from the UB has described for the first time the molecular self-assembly process of this key protein and has revealed ...